Rodent Genetic Engineering Laboratory Shared Resource

NIH RePORTER · NIH · P30 · $76,778 · view on reporter.nih.gov ↗

Abstract

Abstract/Project Summary RODENT GENETIC ENGINEERING LABORATORY SHARED RESOURCE (RGEL) The Rodent Genetic Engineering Shared Resource Laboratory (RGEL) is a new PCC Shared Resource that offers innovative, comprehensive rodent genetic engineering services that include: CRISPR/Cas9-mediated production of mutant mice, generation of transgenic mice by pronuclear injection of DNA or BAC-DNA, gene targeting in mouse C57BL/6 embryonic stem (ES) cells, generation of fully ESC-derived mice using tetraploid complementation and chimeras with genetically altered ES cells, isolation and establishment of genetically-modified ES cells from existing strains for serial gene targeting, and re-derivation and cryopreservation services for both embryos and sperm. Under the direction of Dr. Sang Yong Kim, who has extensive experience in mouse developmental biology and all aspects of manipulation of the mouse germ line, RGEL is used extensively by PCC investigators to make novel genetically engineered mouse models of cancer (GEMMs), as well as to rederive and store various mouse strains. RGEL accomplishes its goals by means of four Specific Aims: Aim 1) To develop and apply state-of-the-art technology and expertise in support of rodent genetic engineering; Aim 2) To provide highly efficient, cost-effective services in DNA pronuclear injection, gene editing using CRISPR-Cas9 and related systems, blastocyst injection (ES cell, iPS cell), ES cell gene targeting and expansion, embryo tetraploid complementation, embryo rederivation, embryo & sperm cryopreservation, in vitro fertilization (IVF) and transgenic animal genotyping; Aim 3) To leverage expertise in experiment genetics, cell/molecular research and systems biology for genotypic/phenotypic analyses; Aim 4) To provide scientific leadership for a collaborative center of service, technology and expertise in experimental genetic mutation resources.

Key facts

NIH application ID
10124320
Project number
5P30CA016087-40
Recipient
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Principal Investigator
Sang Yong Kim
Activity code
P30
Funding institute
NIH
Fiscal year
2021
Award amount
$76,778
Award type
5
Project period
1997-12-01 → 2024-02-29